Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Sponsor: Centre Hospitalier Universitaire Vaudois
Summary
The goal of this clinical trial research study is to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing a cystectomy. As a secondary focus, this study will aim to develop a signature that would identify patients that would benefit the most from IN. This is a multicentric (Swiss: N=3), prospective, controlled, pragmatic, parallel-group comparative study with block randomization stratified by centers.
Official title: The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy - A Multicenter Randomized Controlled Trial (INCyst Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
232
Start Date
2023-04-10
Completion Date
2026-10
Last Updated
2025-12-09
Healthy Volunteers
No
Conditions
Interventions
Immunonutrition
Immunonutrition: Oral Impact®, Nestlé Health Science, Switzerland. IN will be administered as per manufacturer suggestion, i.e. three times a day during 7 days preoperatively. Oral Impact® is a powdered oral feed that provides 309 kcal/bag
Locations (4)
Centre Hospitalier Universitaire Vaudois, CHUV
Lausanne, Canton of Vaud, Switzerland
University Hospital of Bern
Bern, Switzerland
University Hospital of Geneva
Geneva, Switzerland
Hospital of Riviera-Chablais
Rennaz, Switzerland